DR info

Clinical trials : 88 / Drugs : 81 - (DrugBank : 21) / Drug target genes : 15 - Drug target pathways : 90

Microscopic polyangiitis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
43	Microscopic polyangiitis
44	Wegener granulomatosis
13	Multiple sclerosis/Neuromyelitis optica
46	Malignant rheumatoid arthritis
42	Polyarteritis nodosa
51	Scleroderma
45	Eosinophilic granulomatosis with Polyangiitis
96	Crohn disease
41	Giant cell arteritis
11	Myasthenia gravis
53	Sjogren syndrome
49	Systemic lupus erythematosus
40	Takayasu arteritis
162	Pemphigoid
222	Primary nephrotic syndrome
84	Sarcoidosis
85	Idiopathic interstitial pneumonia
97	Ulcerative colitis
284	Diamond-Blackfan anemia
35	Pemphigus
285	Fanconi anemia
271	Ankylosing spondylitis
60	Aplastic anemia
50	Dermatomyositis
300	IgG4-related disease
226	Interstitial cystitis with Hunners ulcer
19	Lysosomal storage disease
65	Primary immunodeficiency
283	Acquired pure red cell aplasia
62	Paroxysmal nocturnal hemoglobinuria
331	Idiopathic multicentric castleman disease
164	Oculocutaneous albinism
66	IgA nephropathy
93	Primary biliary cholangitis
56	Behcet disease
55	Relapsing polychondritis
2	Amyotrophic lateral sclerosis
94	Primary sclerosing cholangitis
61	Autoimmune hemolytic anemia
107	Juvenile idiopathic arthritis
298	Hereditary pancreatitis
6	Parkinson disease
270	Chronic recurrent multifocal osteomyelitis
95	Autoimmune hepatitis
228	Bronchiolitis obliterans
172	Hypophosphatasia
36	Epidermolysis bullosa
70	Spinal stenosis
28	Systemic amyloidosis
10	Charcot-Marie-Tooth disease
86	Pulmonary arterial hypertension
14	Chronic inflammatory demyelinating polyneuropathy
224	Purpura nephritis
269	Pyogenic arthritis
54	Adult still disease
52	Mixed connective tissue disease
220	Rapidly progressive glomerulonephritis
30	Distal myopathy